LNSR — LENSAR, Inc.

LENSAR Q4 2024 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: $16.7 million, a 38% increase from $12.1 million in Q4 2023.
• Full Year Revenue: $40 million, representing a 27% growth over 2023.
• Recurring Revenue: Approximately $10.8 million in Q4, with total recurring revenue for the year at $40 million.
• Gross Margin: 42% in Q4, consistent with 43% in Q4 2023; full-year gross margin at 48%.
• Net Loss: $18.7 million or $1.61 per share in Q4, compared to a loss of $3.9 million or $0.35 per share in Q4 2023, primarily due to a $17.6 million noncash charge related to warrant liabilities.
• Adjusted EBITDA: Positive $478,000 in Q4, compared to a negative $1.2 million in Q4 2023.
• Cash Position: $22.5 million as of December 31, 2024, down from $24.6 million a year earlier, but increased by $3.9 million during Q4.

2. Strategic Updates and Business Highlights

• System Placements: 31 ALLY Systems placed in Q4, with 20 in the U.S., marking a new quarterly high.
• Market Share Growth: LENSAR gained an additional 7.5% market share in U.S. procedures, totaling nearly 21%.
• New Customers: 75% of new system placements were with customers new to LENSAR, indicating a strong adoption of the ALLY technology.
• International Expansion: Continued growth in Europe and Southeast Asia with 24 systems installed since mid-August 2024.
• Operational Efficiency: Increased productivity as practices integrate ALLY into operating rooms, enhancing procedure volumes.

3. Forward Guidance and Outlook

• 2025 Revenue Growth: Expected to exceed 27% growth achieved in 2024, with first-quarter growth aligning with 2024's rate.
• Gross Margin Expectations: Anticipated to reach approximately 50% in 2025, with higher margins from procedure-based revenues.
• Adjusted EBITDA: Positive results expected for the full year of 2025, with increasing profitability as the year progresses.
• Strategic Investments: Continued investment in commercial operations and customer service to support growth.

4. Bad News, Challenges, or Points of Concern

• Net Loss Increase: Significant net loss attributed to noncash charges, raising concerns about profitability.
• Recurring Revenue Shift: A decrease in recurring revenue percentage (64% in Q4 2024 vs. 73% in Q4 2023) reflects increased system sales impacting overall revenue mix.
• Competitive Landscape: Ongoing competition from larger players in the market, with no immediate technological threats but a need to maintain market share against bundled offerings from competitors.

5. Notable Q&A Insights

• Market Strategy: The company is successfully targeting new customers and replacing older systems, with a focus on private equity groups and larger practices.
• Sales Mix: Anticipated shift in sales mix towards placements as demand increases, with a target of 50-60% placements in 2025.
• International Sales Growth: Gradual growth expected in international markets, with larger growth anticipated in 2026.
• Direct Presence Consideration: Future discussions on establishing a direct presence in certain markets, although current distributor relationships are strong.

Overall, LENSAR demonstrated strong growth in Q4 2024 and for the full year, with promising strategic initiatives and an optimistic outlook for 2025, despite facing challenges related to net losses and competitive pressures.